Skip to main content
. 2020 Sep 22;2(5):e671–e676. doi: 10.1016/j.asmr.2020.07.005

Table 2.

Clinical Outcomes

Author Outcome Measure Outcome Score
CCD, mm
Revisions
Malreduction
Complications
(SB/HP) (SB/HP) (SB/HP) (SB/HP) (SB/HP)
Athar et al., 201811 NA NA NA 31.8%/42.3% 25%/3.8% 54.2%/32.7%
Bin Abd Razak et al., 20184 Constant–Murley score 87.6/77.5 11.8/13.6 0%/0% NA 0%/30%
VAS score 1/1
Jensen et al., 201412 Constant–Murley score 89/88 23.8/23.0 11.5%/13.3% NA 11.5%/13.3%
Taft score 10/10
VAS score 1.3/1.7
Natera-Cisneros et al., 201620 Constant–Murley score 95.3/91.3 NA 5%/9.1% 40%/36.3% 15%/18.2%
VAS score 0.4/1.5
Stein et al., 201813 Constant–Murley score 95.3/90.1 16.9/19.4 NA NA NA
Taft score 10.9/9.4
VAS score 1.7/2.4
Zhang et al., 201821 Constant–Murley score 95.1/85.8 7.5/7.5 NA NA NA

CCD, coracoclavicular distance; HP, hook plate; LOE, level of evidence; NA, not applicable; SB, suture button; VAS, visual analog scale.

Denotes statistically significant result.